Simple Testing. Innovative Technology.
Bayer’s CONTOUR® USB Meter is the first and only blood glucose meter with plug-in technology for diabetes management.
Discover a unique testing experience with Bayer’s CONTOUR® USB meter.
Bayer’s CONTOUR® USB meter connects you to a new level of diabetes management. It makes it easy for you to access the knowledge you need to share with your healthcare professional in order to modify your routine and manage your diabetes.
EASY TO USE
In a recent study, 98.3% of patients positively rated the usability of the CONTOUR® USB meter.3
GLUCOFACTS® DELUXE diabetes management software can help you keep track of your blood glucose levels. To learn more about GLUCOFACTS® DELUXE, click here.
References:
- 1.AACE. Endocr Pract. 2007;13(suppl):3-68.
- 2.IDF. Guideline for management of postmeal glucose. 2007. http://www.idf.org/webdata/docs/Guideline_PMG_final.pdf.
- 3.Schwedes U, Petruschke T, Führer K. Non interventional study to investigate suitability for daily use of blood glucose meter CONTOUR®USB in routine application in insulin-treated diabetic patients [sponsored by Bayer]. Poster presented at: Diabetes Technology Meeting; November 11-13, 2010; Bethesda, MD.
Bayer's easy-to-use CONTOUR®USB meter helps patients transform testing into understanding
The CONTOUR® USB meter diabetes management system helps you:
- Evaluate a patient’s glucose control2
- Have more effective patient interactions2
- Easily identify problem areas2 and helps your patients:
- Understand testing data
- Easily identify trends
Help transform testing into understanding. . . prescribe a CONTOUR®USB meter and CONTOUR® test strips today! .
GLUCOFACTS® DELUXE diabetes management software can help your patients keep track of their blood glucose levels. To learn more about GLUCOFACTS® DELUXE, click here.
References:
- 1.Data on file, Bayer HealthCare Diabetes Care
- 2.Schwedes U, Petruschke T, Führer K. Non interventional study to investigate suitability for daily use of blood glucose meter CONTOUR®USB in routine application in insulin-treated diabetic patients [sponsored by Bayer]. Poster presented at: Diabetes Technology Meeting; November 11-13, 2010; Bethesda, MD.